Safety and Efficacy of Ranibizumab for Diabetic Macular Edema

NCT01982435 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Ranibizumab
DRUG: Ranibizumab

Sponsor

Justis Ehlers

Collaborators

[object Object]